Metastases are responsible for 90% of cancer-related deaths. Initiation of metas-9 tases, where newly seeded tumor cells expand into colonies, presents a tremendous 10 bottleneck to metastasis formation. Despite its clinical importance, our under-11 standing of this process is very limited. Here, we propose a simple stochastic model 12 assuming that the initiating metastatic cells proliferate faster when surrounded by 13 more of their kind. The model quantifies the severity of metastatic bottleneck as 14 the probability that the seeded colony survives. Based on this model, we derive how 15 metastasis occurrence depends on primary tumor size and affects patient outcome. 16 Our predictions agree with epidemiological data for thirteen cancer types. The 17 model predicts that impact of treatment decisions depends both on the primary 18 tumor size and on the severity of the metastatic bottleneck, and that medical inter-19 ventions that tighten the bottleneck would be much more efficient than therapies 20 that decrease overall tumor burden, such as chemotherapy. 21 1 2 EWA SZCZUREK 1 , TYLL KRUEGER 2 , BARBARA KLINK 3,4 , AND NIKO BEERENWINKEL 5,6 metastases (25). This further supports the causative, and not only correlative, de-69 pendence of metastatic incidence on tumor size. The exact description, however, of 70 how tumor size affects metastasis probability in the presence of colonization bot-71 tleneck and how patient outcome in turn depends on metastasis probability, is still 72 lacking.
Introduction 22
Metastasis formation is a multi-step process, in which tumor cells spread from the 23 primary site and colonize distant organs (1) . Metastases are responsible for 90% of 24 deaths from cancer (2, 3) , yet their formation is known to be highly inefficient (4-6). Figure 1 . Modeling metastasis formation process and its bottleneck. a Three phases of metastasis formation, Phases 1 and 3 being very efficient. In Phase 1, tumor cells are constantly released into the blood stream. Given that larger tumors can release more cells over time, they have a higher chance to develop metastases. Thus, a dependency of metastasis probability and patient outcome on tumor size is expected. The bottleneck is the metastasis initiation in Phase 2. b Stochastic birth-and-death process of metastasis initiation. For each cell in the forming colony, the ratio of its proliferation rate λ i to its death rate µ i depends on the total number of cells i with a proportionality constant 1 b . c The bottleneck severity b is the critical colony size for metastasis initiation. The probability of colony survival starting from i cells is lower than 0.5 (gray horizontal line) when i < b and larger than 0.5 when i > b, and increases rapidly when i crosses b. At the point when the colony has b cells, the jump probability that the colony will increase its size by one equals roughly 0.5. b = 19, red, is a median bottleneck commonly observed in our model; Figure 4 ) d Model parameters on a timescale. From tumor onset to diagnosis, the tumor grows and releases cells. Once a metastasis is successfully initiated, it takes a cancer-specific average number of years δ 0 until it becomes lethal. The initiated metastases grow on average δ 1 years to become large enough to be detectable by screening. With a certain probability, decreasing with metastasis age, and parametrized by the expected age a when metastases become irremovable, treatment may remove metastasis. Also due to treatment, time to death is prolonged by a constant h. phase of metastasis formation, we assume that as the primary tumor grows, it con-177 tinues to release cells from its surface. Primary tumor growth is modeled as an 178 exponentially increasing spherical volume with the doubling time set to constants 179 measured for different cancers (Table S3 ). The per-cell per-year release rate is fixed 180 to match experimental data, showing that a tumor of one gram contains about 181 10 9 cells (39) and that such a tumor sheds around 1.5 × 10 5 cells per day (26).
182
The extravasation probability is fixed to 0.8, based on experimental observations in 183 mice (15) (Methods).
184
To model the second, extremely inefficient phase of metastasis initiation, we rely 185 on the observation that metastatic propensity increases with colony size (21, 22), 186 which is expected for colony outgrowth up to certain limit size. Accordingly, our 187 model is an inhomogeneous birth-death process, where the ratio of proliferation to as the colony size increases from smaller than b to larger than b, the probability of 193 survival of the colony grows dramatically from very small to very large ( Figure 1c ). fit the data extremely well ( Figure 3 and Figure S1 , blue curves). Fits to other 227 quantile time to death data are comparable to the fits to the median ( Figure S2 ).
228
The ovarian cancer data was excluded from this analysis because it was the only 229 cancer type which did not show dependence of patient outcome on tumor size, and 230 therefore did not fit our model assumptions ( Figure 2 Figure S1 for remaining ten). Black points represent data records, blue lines show fitted, and red lines predicted curves. a For cancer death probability, up and down-oriented triangles present the upper and lower estimates of that variable from the data, respectively, while the black dots represent a Kaplan-Meier (KM) derived estimate (Methods). In agreement with the data, we model cancer death frequency (right) as the probability of metastasis that were not removed by treatment, which accounts also for undetectable metastases and is thus larger than metastasis detection probability (left). b Despite the fact that the median time to death data for all patients (left panel), which was used for model fitting, is tumor-size dependent, the model correctly predicts the much shorter median time to death for patients with metastases detected at diagnosis, and that this time is virtually constant across tumor diameters (right). c Independent validation on survival data for two pancreatic cancer cohorts: Autopsy and Adjuvant, analyzed by (35) (black, with gray confidence bands). We predict their survival function using our pancreas cancer model, fit solely to SEER data, and accessing only information about tumor diameters of patients in the cohorts. For both cohorts, our predictions (red curves) are as close to the data as predictions obtained from the the Haeno et al. model (orange).
Met detection
we fitted to pancreatic cancer data from the SEER, we very closely predict the sur-250 vival functions of these two independent cohorts using only their primary tumor 251 diameters (Figure 3c ; Methods). Our predictions are as close to the data as those 252 obtained from the model of (35), which, however, was fitted to the Autopsy cohort 253 itself, having access not only to tumor diameters and clinical information but also 254 to counts and sizes of metastatic lesions determined at autopsy. 2.5. Predicted impact is most dramatic for treatment aiming at increas-284 ing bottleneck severity. Finally, we apply our model to predict impact of three 285 different treatment decisions on cancer death risk ( Figure 5 and Figure S3 ). Specif-286 ically, we consider how cancer death probability will increase or decrease due to (i) colony starting from a single tumor cell that had infiltrated into a secondary organ. 470 We assume that initially, the larger the colony manages to grow, the easier it is for 471 its cells to divide. At this stage, cell population is much too small for the tumor cells 472 to compete against each other for nutrition and oxygen, and to exhibit hypoxia and 473 necrosis, which result from over-crowding. Thus, we model the initial metastatic 474 colony growth as a continuous-time binary branching process, where each state 475 i is the total number of cells in the colony. We define the ratio of the cellular 476 proliferation rate λ i and the death rate µ i as an increasing function of i,
where b is a proportionality constant, which we call the bottleneck severity. Intu-478 itively, the larger the severity b, the stronger the metastatic bottleneck. Indeed, 479 the larger b, the smaller the proliferation to death rate ratio. For a population of i 480 cells, the individual rates λ i and µ i correspond to the population proliferation rate 481 i · λ i = i 2 µ i /b and the population death rate i · µ i , respectively.
482
Let 483
(2) p i = λ i λ i + µ i denote the jump probability from state i to i + 1, and 1 − p i the probability for 484 the jump from i into i − 1. The jump probability fully describes the stochastic 485 dynamics of the population, and it depends only on the combined proliferation and 486 death rates. Intuitively, for large jump probability p i the colony size will likely 487 increase in the next step, while for small p i it will likely decrease. The critical 488 colony size is reached when this probability passes 1/2. More precisely, the smallest 489 total number of cells that results in jump probability larger or equal than 1/2 is 490 called the critical size. Inserting the rates in relation described by (1) into Equation
491
(2), we find that the critical size is equal to
This branching process is a birth and death chain with a single absorbing state Methods. First, it is of course not possible that the proliferation to death ratio goes 509 to infinity with increasing colony size. We show, however, that a model assuming 510 a truncation to a constant ratio after the colony grows large, would yield only 511 negligibly different probabilities of colony survival. Second, we discuss that the 512 model described here does not specify the timing of the stochastic process of colony 513 initialization, but that it can once average cell death rate was measured. Finally,
514
here we simply assumed that the dependence of proliferation to death ratio on i is For a given fixed time point t * ≤ t(d), to compute N (t * ), we consider the per tumor
The rate Y (t) increases with the tumor volume X (t), measured in cm 3 . With 540 additional assumptions of spherical tumor shape and that the majority of cells 541 released from the tumor originate from the tumor surface,
where the constant u is the per-cell per-year release rate of cells from tumor surface, 543 v is the extravasation probability, X(t) is the volume of the tumor in cm 3 and 10 9
544
gives the number of cells in unit (1cm 3 ) volume. To set a realistic release rate u, 545 we assumed that for all cancer types, there are 10 9 cells in a tumor weighting a where at time t = 0 the tumor volume is X 0 = 10 −4 cm 3 , corresponding to 10 5 cells 557 (with volume of a single cell of 10 −9 cm 3 ). This initial condition X 0 is chosen to 558 make sure that with X 0 , the tumor growth has already passed its early stage of low 559 cell count, in which growth dynamics may be stochastic rather than deterministic.
560
The growth rates r are different for each cancer type and fixed to literature-derived 561 constants (Table S3 ). With these assumptions, we can compute the integral 562
where the constant c = (4π) 1/3 · 3 2/3 · X 2/3 0 · 10 6 . This fully defines M (t; b) (Equa-564 tion 3).
565
With the assumptions of exponential growth for the primary tumor and from the 566 volume formula for its spherical shape we have
and obtain that a tumor of diameter d has age
To define the metastasis probability as a function of diameter instead of time, we 571 simply use Equation (4) together with (6) and denote 572 (7)
Importantly, metastasis probability M (d, b) is expected to be much larger than the 573 metastasis detection probability, i.e., incidence of detected metastases in patients 574 with the same tumor size, as it accounts for the probability of having micrometas-575 tases, which are not detectable by current screening techniques.
576
Cancer death probability for patients with given tumor size. Given the fact 577 that metastases account for circa 90% of cancer deaths, the cancer death probability 578 should depend on the metastasis probability. To make this relationship explicit in 579 the model, we first assume that in order to die of cancer, it is sufficient to have at 580 least one successful metastasis at a distant site. Second, we focus only on patients 581 who had tumors resected following the diagnosis, and assume that the surgery fully 582 removes the source of metastatic seeding. Third, we also account for the trivial 583 fact that patients presenting at diagnosis are alive and their lives were thus not 584 yet threatened by the metastases. To this end, we assume that there is a certain, Here, for a given time point t * 610 
where the integral in the second term can be further simplified to 
where the last line follows from Equation 4. To account for the variability of the 665 bottleneck, as above we use the marginal probability with respect to the log normal 666 distribution of b with parameters µ and σ. In addition, we use the post-treatment metastasis probabilities, assuming, again as above, that treatment may remove some 668 of the life-threatening metastases. We thus find x q as the root of the equation
The quantile time to death is then given by
where h is an additional treatment-related parameter that accounts for the increase 
for x ′ q , and the quantile time to death for patients with metastases detectable at 681 diagnosis is then given by
Model fitting. The model was fitted to metastasis detection rate and quantile 683 times to death for different tumor diameters, obtained from the SEER database, 9). Here, we assume that metastasis which originated 691 5 years before the diagnosis can be removed with probability at most 1%.
692
The quantile times to death were computed from the data for eleven different quan- 
Finally, we predict the impact of increase of the median of the bottleneck distribu-729 tion by a factor c 2 > 1. Such an increase would correspond to the mechanism of 730 action of vaccines, where we would be able to strengthen the defense of the immune 
741
In Figure S3 we compare the results for δ = 16 weeks with δ = 8 weeks, as well as Tables  Table S1 . Overview of analyzed cancer types with minimum follow up times and number of cases included after filtering from the SEER (37) database. For each cancer type, we provide a short name that is used throughout the manuscript. For each type, we defined a designated minimum follow-up time that ensures a sufficient number of patients for calculating representative statistics of frequency of metastasis detection, frequency of cancer death and quantile times to death. Generally, the minimum follow up times were a compromise between the requirement of long monitoring time after diagnosis, and the resulting sample sizes for each cancer. The minimum follow-up time differs between different cancer types, reflecting their clinical behavior. For example, for more aggressive cancers, such as pancreatic and esophageal cancer, which have a poor prognosis, a shorter minimum follow-up time was allowed. In contrast, for breast cancer, where the ten year survival rate for all stages is nearly 80%, the minimum follow-up was set to 20 years. This still allowed for a very large sample size of 35949 patients, since breast cancer is one of the most common cancer types. Table S3 . Per-cancer tumor growth rates fixed for thirteen modeled cancer types.
Supplementary
For each cancer type, we list the tumor doubling time in days, denoted D, as found reported (usually as median or mean value across a measured population) in the cited references. The per year exponential growth rate r in our model, was then computed from those doubling times as D · ln(2)/365.24. For several cancer types, we were unable to find measured doubling times. For those cancer types, we fixed the corresponding rates to ones measured in the most similar cancer type. Specifically, for endometrial cancer, we fixed the doubling rate to the rate reported in another female cancer, breast. For esophageal, gastric and bladder cancer types, we fixed the rate as reported for colon and rectum. Figure S1 . Fit and validation of the model on the SEER data, for ten cancer types (rows, alphabetically ordered), not featured in Figure 3 . Black points represent data records, blue lines show fitted, and red lines predicted curves. The model fits the data perfectly. a For cancer death probability, up and down-oriented triangles present the upper and lower estimates of that variable from the data, respectively, while the black dots represent a Kaplan-Meier (KM) derived estimate (Methods). In agreement with the data, we model cancer death frequency (right panel) as the probability of metastasis which were not removed by treatment, which accounts also for undetectable metastases and is thus larger than metastasis detection probability (left panel).
Cancer
b Despite the fact that the median time to death data for all patients (left panel), which was used for model fitting is tumor-size dependent, the model correctly predicts that median time to death for patients with metastases detected at diagnosis (right panel) is constant across tumor diameters. Figure S2 . Summary of the model fit. For thirteen different cancer types, their fit to the data is measured using root mean squared error (RMSE). The cancer types (rows) are ordered by the increasing mean RMSE of the fit to quantile time to death data. a Low RMSE values indicate very good agreement of the model with metastasis detection probability (as visualized also in Figure 3a and Figure S1a , blue lines). The largest RMSE is obtained for pancreatic cancer, for which also the largest absolute metastasis detection probability is recorded (see Figure S1a ). b Similarly good fit is obtained for quantile time to death data, for eleven different quantiles (x-axis). Larger RMSE values than for metastasis detection probability in (a) are due to the fact that quantile time to death is in measured in (usually, several) years. The fit to 0.5-th quantile (median) is visualized also in Fig. 3b and Figure S1b . The RMSE for other quantiles is comparable to the RMSE obtained for the median (0.50-th quantile) time to death data. Figure S3 . Predicted impact of treatment decisions. Change in cancer death probability (yaxis) due to treatment change depends on tumor diameter (x-axis) and bottleneck severity (colors), shown for ten cancers not featured in Figure 4 in the main text (rows; ordered alphabetically 
We will now show that for this model the metastasis success probability s 1 , equal to the probability that the colony starting from single cell will not go extinct, is given by
while the probability of colony survival starting from i > 1 cells equals
where F P ois (i; b) denotes a cumulative Poisson distribution function with parameter b, evaluated at value i.
In a birth and death chain with a single absorbing state i = 0, the probability of success of the metastasis starting from state i can be computed with the recursion (1, 2)
where p i denotes the probability of jumping from the state of i to i + 1 cells
Setting a i = 1 p i − 1, with s 0 = 0, and rearranging terms we obtain Discussion of timing of the stochastic process of metastasis initiation. The assumption of the birth to death ratio satisfying Equation (1) does not define the timing of events in the process. The assumption is enough to derive the probabilities of metastatic success, which, as shown above, do not depend on the particular values of birth λ i and death rates µ i .
To describe the timing of this process, a convenient way would be to set
In such a way, we could model the real time behavior of the process, where the time unit would be the mean time to death. Thus, realistic time predictions would depend on the measurement of average time to death of cells in a growing metastatic colony.
Generalization of the metastasis initiation model. In the general case, we will consider the following assumption about the ratio of rates λ i and µ i for cell division and death, respectively:
Here, the exponent α defines the nature of the dependence of proliferation to death rate ratio on colony size. We set α = 1, as in the main text, to define linear dependence. Another choice of α = 1/3 would correspond to the assumption that the proliferation rate depends on the ratio of the number of cells on the surface to the total number of cells in the colony, assuming spherical metastasis growth (see below). For a population of cells of size i, the individual rates λ i and µ i correspond to population proliferation rate i · λ i = i α+1 /(b) α · µ i and population death rate i · µ i , respectively. We will now derive approximation for the metastasis survival probability in this general case.
Let α ̸ = 1. Following the same argument as above, we can derive (12)
We have: The Poisson distribution with parameter b sufficiently large is well approximated by the the normal distribution with variance b (and mean b). Thus, for the Poisson distribution with rate b its Renyi entropy, denoted h P ois (b), becomes
Simplifying, we obtain
which leads to To consider a possible biologically relevant value of α ̸ = 1, we discuss a scenario where the forming colony is a sphere and where, out of all cells in the colony, the cells on the sphere surface are most vulnerable, due to exposure to the surrounding environment. We can further approximate that the total number of cells i is on the order of the volume of the sphere, i = O(ρ 3 ), and the number of the cells on its surface is j = O(ρ 2 ), where ρ denotes the radius of the sphere. Thus, j = O(i 2/3 ). Assuming that the proliferation rate of cells in the colony depends on the ratio i/j = i 1/3 between the total to the number of cells on the surface we obtain
Thus, for spherical metastases, the model parameter is α = 1 3 , and the survival probability becomes
.
